Metaxin Is a Component of a Preprotein Import Complex in the Outer Membrane of the Mammalian Mitochondrion*

(Received for publication, November 18, 1996, and in revised form, January 3, 1997)

Lucas C. Armstrong Dagger §, Tohru Komiya , Bradford E. Bergman Dagger , Katsuyoshi Mihara and Paul Bornstein Dagger par

From the Dagger  Department of Biochemistry, University of Washington, Seattle, Washington 98195 and the  Department of Molecular Biology, Graduate School of Medical Science, Kyushu University, Fukuoka 812, Japan

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

Metaxin, a novel gene located between the glucocerebrosidase and thrombospondin 3 genes in the mouse, is essential for survival of the postimplantation mouse embryo. In this study, the subcellular location, domain structure, and biochemical function of metaxin were investigated. Anti-recombinant metaxin antibodies recognized 35- and 70-kDa proteins in mitochondria from various tissues; the 35-kDa protein is consistent in size with the predicted translation product of metaxin cDNA. When metaxin cDNA was transfected into COS cells, immunofluorescence staining demonstrated that the protein is located in mitochondria. Metaxin contains a putative mitochondrial outer membrane signal anchor domain at its C terminus, and a truncated form of metaxin lacking this signal anchor domain had a reduced association with mitochondria. In addition, metaxin was highly susceptible to proteases in intact mitochondria. We therefore conclude that metaxin is a mitochondrial protein that extends into the cytosol while anchored into the outer membrane at its C terminus. In its N-terminal region, metaxin shows significant sequence identity to Tom37, a component of the outer membrane portion of the mitochondrial preprotein translocation apparatus in Saccharomyces cerevisiae, but important structural differences, including apparently different mechanisms of targeting to membranes, also exist between the two proteins. Given the similar subcellular locations of metaxin and Tom37, the possible role of metaxin in mitochondrial preprotein import was investigated. Antibodies against metaxin, when preincubated with mitochondria, partially inhibited the uptake of radiolabeled preadrenodoxin into mitochondria. Metaxin is therefore the second mammalian component of the protein translocation apparatus of the mitochondrial outer membrane to be characterized at the molecular level and the first for which an inherited mutation has been described. The early embryonic lethal phenotype of mice lacking metaxin demonstrates that efficient import of proteins into mitochondria is crucial for cellular survival. The characterization of metaxin provides an opportunity to elucidate similarities and possible differences in the mechanisms of protein import between fungi and mammals and in the phenotypes of fungi and mammals lacking mitochondrial import receptors.


INTRODUCTION

During studies of thrombospondin 3 (Thbs3), which encodes an extracellular matrix protein (2-4), and glucocerebrosidase (Gba), which encodes a lysosomal enzyme (5), a novel gene, termed metaxin (Mtx), was found to span the interval between Thbs3 and Gba on chromosome 3E3-F1 in the mouse (6). Mtx and Thbs3 are situated in a head-to-head orientation, with the translation start sites 1.4 kilobase pairs apart. Gba and Mtx lie in a tail-to-tail orientation, with the polyadenylation sites spaced 431 base pairs apart. The Mtx promoter resembles the promoters for housekeeping genes in that it is TATA-less, GC-rich, and regulated by tandem Sp1 elements within 300 base pairs of the transcription start site (7). Although the close apposition and head-to-head orientation of Mtx and Thbs3 raise the possibility that the two genes share a bidirectional promoter, several lines of evidence suggest that these genes are regulated independently. First, Mtx mRNA is ubiquitously distributed in the mouse, whereas Thbs3 mRNA is restricted to lung, cartilage, the gastrointestinal tract, and hippocampus (2, 8, 9). Secondly, the basal elements of the Mtx and Thbs3 promoters can largely be dissociated, which indicates that the Mtx and Thbs3 genes are not regulated by a true bidirectional promoter (7).

In the process of producing a subtle mutation in Gba, a neomycin cassette was inadvertently placed in exon 8 of Mtx (6). Mice homozygous for this disruption have an embryonic lethal phenotype, indicating that metaxin is necessary for the early development of the mouse embryo. This severe phenotype is in contrast to the phenotype of mice lacking glucocerebrosidase, which die shortly after birth with Gaucher disease-like symptoms. Because Mtx mRNA is ubiquitously expressed in the adult mouse, it is likely that metaxin has a fundamental role in an as-yet-undefined cellular process. To gain insight into its function and to examine the possible metabolic relationship between metaxin and glucocerebrosidase and/or thrombospondin 3, we have investigated the subcellular location of metaxin and have found that it is a mitochondrial outer membrane protein. Metaxin has significant sequence identity to a component of the yeast mitochondrial protein import machinery, Tom37 (10). We demonstrate here that metaxin also functions in the import of mitochondrial preproteins into mammalian mitochondria, although its mode of function may differ in important respects from that of Tom37.


EXPERIMENTAL PROCEDURES

Antibodies to Metaxin

A full-length mouse metaxin cDNA was placed in frame with the GST1 gene in pGEX2T (Pharmacia Biotech Inc.) or with the polyhistidine gene of pTrcHis (Invitrogen). The resulting GST-metaxin fusion protein, synthesized in Escherichia coli, was insoluble and was partially purified by fractionation of inclusion bodies. The polyhistidine/metaxin fusion protein was also insoluble and was purified from guanidinium-solubilized inclusion bodies on a ProBond nickel affinity column under denaturing conditions, as described by the manufacturer (Invitrogen). Inclusion bodies containing GST-metaxin were cleaved with thrombin, and the metaxin portion was purified by electrophoresis and electroelution. The electroeluted metaxin was injected into guinea pigs, and antibodies specific to metaxin were affinity-purified on a column of polyhistidine/metaxin coupled to CNBr-activated Sepharose.

Preparation of Tissue Lysates and Liver Subcellular Fractions

Tissue lysates were prepared by homogenization with a Dounce homogenizer in 100 mM Tris, pH 7.5, 10 mM EDTA, 150 mM NaCl, 1% SDS, 1 mM leupeptin. Subcellular fractions of mouse liver were obtained as described (11). Purity of the fractions was assessed by assays for DNA, citrate synthase (12), acid phosphatase (13), lactate dehydrogenase (14), Na+/K+ ATPase (15), and glucose 6-phosphatase (16). Western blot analysis was performed with anti-metaxin antibodies at a 1:500 dilution and with a secondary anti-guinea pig IgG-alkaline phosphatase conjugate. Blots were developed with a nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate substrate.

Immunofluorescence Analysis of COS Cells Expressing Mouse Metaxin cDNA

Metaxin was placed under control of the cytomegalovirus promoter in pcDNA3 (Invitrogen) and transfected into COS cells by electroporation. Electroporations were performed in a BRL Cell-Porator set at 150 V, 800 microfarads, with a 0.4-cm cuvette containing 1.5 × 106 cells in 500 µl of 20 mM HEPES, pH 7.05, 137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 6 mM dextrose, 1 mg/ml bovine serum albumin. Cells were plated at a concentration of 1 × 105 cells/ml into either glass chamber slides (for immunofluorescence) or tissue culture dishes (for cell lysis). After 48 h, cells were lysed with 100 mM Tris, pH 7.5, 10 mM EDTA, 150 mM NaCl, 1% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride and examined by Western blotting. Cells in chamber slides were fixed with 3% paraformaldehyde, 1% sucrose, 1 mM CaCl2, 10 mM MgCl2 in phosphate-buffered saline and permeabilized in ethanol. Indirect immunofluorescence staining for metaxin was performed with 1:200 diluted affinity-purified anti-metaxin antibody and 1:200 anti-guinea pig IgG-fluorescein conjugate. In some experiments, prior to fixation, the cells were incubated with serum-free Dulbecco's modified Eagle's medium containing 100 nM MitoTrackerTM (Molecular Probes). Confocal microscropy was performed with a Bio-Rad MRC 600 confocal laser scanning microscope (W. M. Keck Center for Advanced Studies in Neural Signaling, University of Washington), with excitation settings of 488 and 568 nm that emitted in the green and red, respectively.

Construction of Metaxin Truncations and Fusions

The metaxin deletion construct, pcDNA3metDelta C, spans amino acids 1- 303 and was constructed by ligating the EcoRI-ApaI fragment of the metaxin cDNA to pcDNA3. The deletion construct, pcDNA3metDelta TM/C, spans amino acids 1-269 and was constructed by ligating the EcoRI-BglI fragment of metaxin to pcDNA3. These constructs were transfected into COS cells and examined by immunofluorescence and Western blotting as above, except that a horseradish peroxidase-conjugated secondary antibody and an enhanced chemiluminescence detection method (ECL, Amersham Corp.) were used to visualize metaxin. Densitometric analysis of Western blots was performed with a Bio-Rad GS-670 Imaging Densitometer. Stable cell populations expressing intact and truncated forms of metaxin were prepared by incubating transfected COS cells in Dulbecco's modified Eagle's medium with 10% calf serum and 800 µg/ml G418.

The enhanced green fluorescent protein vector pEGFP C1 (Clontech) was utilized to examine the targeting domain of metaxin. The EGFP/metaxin C-terminal fragment fusion vector, pEGFPmetC, encodes EGFP followed by amino acids 260-317 of metaxin. COS cells transfected with EGFP expression vectors were incubated with MitoTracker, fixed with paraformaldehyde, and analyzed by confocal microscopy, as above. Immunoblotting for EGFP was performed with a rabbit anti-EGFP antiserum (Clontech) at a 1:2000 dilution.

Submitochondrial Distribution of Metaxin

Mitochondria were prepared as described (17), and mitoplasts were prepared by incubating 10 mg/ml mitochondria with 2 mg/ml digitonin in Schnaitmann and Greenawalt buffer A (220 mM mannitol, 70 mM sucrose, 2 mM HEPES, pH 7.3) for 15 min on ice. The reaction was diluted 5-fold in buffer A, and mitoplasts were pelleted by centrifugation. For protease sensitivity assays, mitochondria or mitoplasts were incubated at a concentration of 2 mg/ml in buffer A with varying concentrations of trypsin for 30 min at room temperature. The reaction was stopped by the addition of phenylmethylsulfonyl fluoride to 1 mM and soybean trypsin inhibitor to 2.5 mg/ml. The mitochondria or mitoplasts were pelleted at 7000 × g and washed four times in buffer A containing 1 mM phenylmethylsulfonyl fluoride and 2.5 mg/ml soybean trypsin inhibitor. The final pellet was resuspended in SDS-polyacrylamide gel electrophoresis sample buffer containing 7% SDS. Samples were examined by Western blotting with anti-metaxin antibodies (see above) or anti-cytochrome c oxidase subunit IV (Molecular Probes).

Mitochondrial Import Assays

Mitochondrial import of preadrenodoxin was assayed as described previously (18) with a minor modification. Briefly, 125I-labeled preadrenodoxin was incubated with 150-200 µg of rabbit reticulocyte lysate in 50 µl of 20 mM Tris-HCl buffer, pH 7.5, containing 150 mM potassium acetate and 2 mM magnesium acetate at 30 °C for 30 min. The substrate mixture was incubated with mouse liver mitochondria (100 µg) in 100 µl of the "import buffer" (10 mM HEPES-KOH buffer, pH 7.4 containing 1 mM EDTA, 1 mM dithiothreitol, 0.22 M mannitol, and 0.07 M sucrose) containing 5 mM NADH, 20 mM sodium succinate, 0.5 mM ATP, 0.1 mM GTP, 1.5 mM creatine phosphate, and 15 µg/ml creatine phosphokinase at 30 °C for 50 min. Mitochondria were then separated by centrifugation and resolved by SDS-polyacrylamide gel electrophoresis. SDS-polyacrylamide gel electrophoresis gels were analyzed with a Fuji Bioimage Analyzer BAS2000.


RESULTS

Subcellular Distribution of Metaxin

Antibodies against recombinant metaxin recognize a 35- and a 70-kDa protein in lysates of all mouse tissues that were examined (data not shown). The predicted translation product of metaxin cDNA is 317 amino acids in length, which corresponds closely to the 35-kDa band that we observe. The ubiquity of metaxin protein is in keeping with the wide distribution of metaxin mRNA (6).

Mouse liver was fractionated into its constituent subcellular organelles, and these fractions were assayed for the presence of metaxin by Western blotting (Fig. 1A) and for marker enzymes (not shown). Antibodies against metaxin recognized 35- and 34-kDa bands in mitochondria and in the cytosol, respectively. The 70-kDa band was found solely in mitochondria. To determine whether this subcellular distribution was characteristic of metaxin in other tissues, mouse heart, kidney, liver, and lung were separated into a mitochondrial fraction and a post-mitochondrial supernatant, which contains microsomes and cytosol. In subcellular fractions of mouse heart, kidney, and lung, no cytosolic band was detected, whereas the mitochondrial 35- and 70-kDa bands were present (Fig. 1B). Mitochondrial metaxin has a tissue distribution like that of metaxin mRNA and therefore likely represents the authentic metaxin protein. It is unclear whether the 34-kDa liver cytosolic band is related to metaxin or is a cross-reactive protein. The relationship of the 70-kDa protein to metaxin is also unclear, but the fact that the two proteins are found together in mitochondria and in the same tissues suggests that the 70-kDa form could represent a denaturation-resistant homo- or heterodimer containing the 35-kDa protein.


Fig. 1. Subcellular distribution of metaxin in mouse tissues. A, purified organellar fractions (20 µg/lane) prepared from mouse liver were subjected to Western blot analysis with affinity-purified anti-metaxin as the primary antibody and an alkaline phosphatase detection method. The 35-kDa metaxin protein is found in mitochondria. An additional 70-kDa band also occurs in mitochondria, and a 34-kDa band occurs in the cytosol. B, mitochondrial (mitochondria) and post-mitochondrial supernatant (post-mito S/N) fractions were prepared from mouse liver, lung, kidney, and heart and analyzed by Western blotting with an anti-metaxin antibody. The mitochondrial form of metaxin is found in all four tissues.
[View Larger Version of this Image (33K GIF file)]


The subcellular distribution of metaxin was also determined in cultured cells by immunofluorescence. Several mouse cell lines were stained for metaxin, but the endogenous concentrations of metaxin were too low to permit detection by immunofluorescence. Therefore, COS cells were transiently transfected with a full-length metaxin cDNA, and after 48 h, indirect immunofluorescence was performed with anti-metaxin antibody. The overexpressed metaxin protein had a punctate distribution within the cytoplasm with heavier staining in the perinuclear region that was consistent with a mitochondrial location (Fig. 2a). In addition, weaker diffuse staining throughout the cytosol was observed. Mitochondria were detected by incubation of the cells with MitoTrackerTM dye prior to fixation and staining for metaxin (Fig. 2b). A merged image of the staining for metaxin and mitochondria (Fig. 2c) revealed a partial colocalization (indicated by yellow color). In this experiment, metaxin does have a wider distribution than mitochondria, which can be due to the possibility that overexpressed metaxin has saturated chaperones and/or receptors responsible for its mitochondrial localization. A similar staining pattern was observed in cell lines stably expressing metaxin cDNA (data not shown). In sum, examination of its distribution by immunofluorescence and by subcellular fractionation indicates that metaxin has a mitochondrial location within the cell.


Fig. 2. Immunofluorescence detection of metaxin in COS cells transiently transfected with a metaxin cDNA. COS cells transiently transfected with an expression vector containing the full-length metaxin cDNA were incubated with MitoTrackerTM and then fixed and stained with guinea pig anti-metaxin antibody and fluorescein-conjugated anti-guinea pig IgG. Images were obtained and analyzed by confocal laser scanning microscopy. a, staining for metaxin (green). b, staining for mitochondria (red). c, merged images of staining for metaxin and mitochondria. The yellow color indicates areas of coincident staining for metaxin and mitochondria. Metaxin appears to be partially associated with mitochondria but is also present at a lesser concentration in the cytosol.
[View Larger Version of this Image (48K GIF file)]


Submitochondrial Location of Metaxin

The majority of proteins that are to be directed to the interior of mitochondria contain a cleavable, N-terminal, amphiphilic, positively charged sequence of 12-70 amino acids that acts as a signal peptide (19). Metaxin contains no positively charged residues within its first 20 amino acids, and a helical wheel projection of the N-terminal 20 amino acids of metaxin did not reveal a predilection toward amphiphilicity (data not shown). Therefore, it is unlikely that metaxin resides in the interior of mitochondria. Near its C terminus, metaxin contains a 23-amino acid stretch of hydrophobic and hydroxy amino acids that is predicted to form a transmembrane sequence by the PHDhtm transmembrane topology prediction computer program (20). This transmembrane sequence is flanked at its N terminus by three consecutive arginine residues and is followed by a sequence of 7 amino acids that contains 2 arginines and no negatively charged amino acids. This sequence motif resembles the C-terminal mitochondrial outer membrane targeting domains of Bcl-2 (21) and monoamine oxidase A (22) (Fig. 3A). Yeast Tom70 contains a motif of similar character but at its N terminus (23).


Fig. 3. Mitochondrial outer membrane localization of metaxin. A, mitochondrial outer membrane proteins contain a continuous stretch of approximately 20 hydrophobic and uncharged amino acids (underlined) near the C or the N terminus, flanked by several positively charged amino acids (denoted by +). Metaxin contains such a sequence near its C terminus. Sequences at the C terminus of metaxinDelta C, which lacks the 15 C-terminal amino acids, and metaxinDelta TM/C, which lacks the transmembrane domain and C-terminal residues, are indicated. B, intact mitochondria were incubated with varying concentrations of trypsin and were then centrifuged. The pellet and the supernatant fraction were analyzed by Western blotting for metaxin and for cytochrome c oxidase subunit IV (COX IV), an inner membrane protein that protrudes into the intermembrane space.
[View Larger Version of this Image (21K GIF file)]


The hypothesis that metaxin is an outer membrane protein with a C-terminal signal anchor sequence and a majority of the protein in the cytosol was first tested by determining its protease susceptibility in intact mitochondria. Mitochondria were incubated with increasing concentrations of trypsin, and the presence of metaxin was examined by Western blotting. Metaxin was found to be susceptible to very low concentrations of trypsin (Fig. 3B). At lower concentrations of trypsin, a 30-kDa proteolytic fragment of metaxin was evident, whereas at higher concentrations, complete disappearance of metaxin was observed. In mitochondria incubated with 1% trypsin (w/w mitochondria), a 30-kDa band also appears in the supernatant (not shown); presumably, the supernatant form is a metaxin fragment lacking a membrane anchor. Under these same conditions, cytochrome c oxidase subunit IV, an inner membrane protein that protrudes into the inner membrane space and is partially cleaved by trypsin in mitoplasts (24), was not digested by trypsin, demonstrating that general degradation of proteins within the interior of the mitochondria did not occur (Fig. 3B, COX IV). However, when the outer membrane of mitochondria was removed from the inner membrane/matrix fraction (mitoplasts), metaxin remained in association with the mitoplast fraction (data not shown). Certain outer membrane proteins, such as Bcl-2, exhibit this behavior, presumably as a result of their association with contact sites between the outer and the inner membrane (21). Interestingly, the 70-kDa cross-reactive species was resistant to trypsin in intact mitochondria but was susceptible in mitoplasts (data not shown).

Metaxin Contains a C-terminal Outer Membrane Targeting Sequence

The requirement for the putative transmembrane sequence in the mitochondrial localization of metaxin was tested by making truncations of the metaxin C-terminal region. The first deletion construct, pcDNA3metDelta C, encodes a metaxin that lacks the C-terminal 15 amino acids, which are not predicted to contain targeting information (Fig. 3A). As judged by indirect immunofluorescence of COS cells transfected with pcDNA3metDelta C, metaxin lacking its C-terminal 15 amino acids retained its mitochondrial location (Fig. 4A, a-c), and furthermore the COS cells appeared to have a lower background of cytosolic staining than did cells transfected with the intact metaxin cDNA. The second deletion construct, pcDNA3metDelta TM/C, encodes a metaxin that lacks the 48 C-terminal amino acids, a region that includes the transmembrane domain (Fig. 3A). The metaxin lacking this transmembrane domain was distributed diffusely throughout the cell (Fig. 4A, d-f), indicating that the transmembrane domain is required for proper mitochondrial distribution of metaxin.


Fig. 4. Effect of C-terminal deletions on mitochondrial targeting of metaxin. A, COS cells transiently transfected with pcDNA3metDelta C (a-c) and metDelta TM/C (d-f) were stained for metaxin (a and d) and mitochondria (b and e) and analyzed by confocal laser scanning microscopy to produce merged images (c and f) as described in Fig. 2. Metaxin Delta C shows a strong association with mitochondria, whereas metaxin Delta TM/C shows little association. B, COS cells stably transfected with pcDNA3 containing no insert (vector), full-length metaxin, metaxin Delta C, or metaxin Delta TM/C were obtained by selection with G418. Cells were fractionated into mitochondrial (mito) and post-mitochondrial supernatant (S/N) fractions, and analyzed by Western blotting for metaxin. Equal amounts of protein (20 µg) were loaded onto each lane. Metaxin was detected by Western blotting with affinity-purified anti-metaxin IgG and horseradish peroxidase-based chemiluminescence. The blot was overexposed to make visible the metaxin bands of lesser intensity. C, bands from Western blots from three separate experiments, as in B, were quantified by scanning densitometry. Total metaxin associated with mitochondria and post-mitochondrial supernatant was calculated; data are expressed as the percentage of metaxin associating with mitochondria (mean ± S.D.).
[View Larger Version of this Image (39K GIF file)]


Stable cell populations expressing full-length metaxin and the two C-terminal deletion constructs were prepared by selection with G418. Mitochondrial and post-mitochondrial supernatant fractions were prepared by differential centrifugation and analyzed for metaxin by Western blotting (Fig. 4B). The percentage of total cellular overexpressed metaxin that was associated with mitochondria was calculated by densitometric analysis of Western blots from three separate experiments (Fig. 4C). Small amounts of metaxin were detectable in the mitochondrial fraction of COS cells transfected with vector alone. COS/metaxin cells accumulated metaxin to a high concentration in the mitochondrial fraction and contained a lower concentration of metaxin in the post-mitochondrial supernatant fraction (Fig. 4B). The percentage of total cellular metaxin associated with mitochondria (28.1 ± 1.2% (mean ± S.D.)) was lower than that in the cytosol (Fig. 4C), because the protein content of the cytosolic fraction is much larger than that of mitochondria. COS/metDelta C cells contained similar concentrations of metaxin in their mitochondria as did COS/metaxin cells (Fig. 4B) but contained less metaxin in the post-mitochondrial supernatant; 67.1 ± 3.9% (mean ± S.D.) of the total cellular metaxinDelta C was associated with mitochondria (Fig. 4C). This difference suggests that the C-terminal 15 amino acids inhibit association of metaxin with mitochondria. COS/metDelta TM/C cells, on the other hand, had reduced concentrations of plasmid-encoded mitochondrial metaxin, compared with COS/metaxin and COS/metDelta C cells (Fig. 4B); only 1.6 ± 1.5% of the total cellular metaxinDelta TM/C (mean ± S.D.) was found in mitochondria (Fig. 4C). Thus, in general, the independent approaches of immunofluorescence and subcellular fractionation give similar estimates of relative cytosolic and mitochondrial concentrations of metaxin.

The C-terminal sequences of Bcl-2 and monoamine oxidase are sufficient to target a heterologous, nonmitochondrial protein to the mitochondrial outer membrane. To test whether the C-terminal region of metaxin is sufficient to act as a mitochondrial outer membrane targeting sequence, the C-terminal amino acids of metaxin (260-317) were fused in frame to EGFP in the pEGFP vector to yield the pEGFPmetC fusion vector. COS cells were transfected with either pEGFP or pEGFPmetC and analyzed by either Western blot or fluorescence. As predicted, anti-EGFP recognized 30- and 35-kDa bands in lysates of cells transfected with pEGFP and pEGFPmetC, respectively (Fig. 5A, anti-EGFP). Anti-metaxin antibody recognized only the 35-kDa band in cell lysates of pEGFPmetC transfected cells, demonstrating that the metaxin portion of the fusion protein was synthesized (Fig. 5A, anti-metaxin). When these cells were analyzed by fluorescence, EGFP was distributed throughout the cell, with a preponderance of the protein in the nucleus (Fig. 5B, a-c). EGFPmetC, on the other hand, was absent from the nucleus and had a restricted distribution in the cytoplasm that only partially overlapped that of mitochondria (Fig. 5B, d-f). The broad distribution of EGFPmetC may be due in part to saturation of the targeting machinery, as may be the case with full-length metaxin. However, EGFPmetC overlaps mitochondria to a lesser extent than does full-length metaxin (Fig. 2c). Therefore, the C-terminal region of metaxin appears to be necessary but not entirely sufficient to direct proteins to the mitochondrial outer membrane.


Fig. 5. EGFP/metaxin C-terminal fragment fusion protein. A, COS cells were transiently transfected with pEGFP or with pEGFPmetC (encoding EGFP followed by the C-terminal 58 amino acids of metaxin) by electroporation. After 48 h, cell lysates were prepared and analyzed by Western blotting with anti-metaxin or anti-EGFP antibodies. B, fluorescence detection of EGFP and an EGFP/metaxin C-terminal fragment fusion protein (EGFPmetC). COS cells transfected as above were stained for mitochondria and fixed in paraformaldehyde. EGFP (a), EGFPmetC (d), and mitochondria (b and e) were detected directly by confocal laser scanning microscopy. EGFP has a diffuse cytoplasmic distribution with a marked concentration in the nucleus. This distribution does not overlap that of mitochondria (c, merged image). EGFPmetC is absent from the nucleus (d) and has a more perinuclear distribution than EGFP but is only partially associated with mitochondria (indicated by the yellow in the merged image (f)).
[View Larger Version of this Image (53K GIF file)]


Metaxin Functions in Mitochondrial Preprotein Import

Several proteins with distant sequence identity to metaxin were detected by searching the protein data bases with the BLAST function. Metaxin has 25% sequence identity over 143 amino acids to Tom37, a yeast protein that is located in the mitochondrial outer membrane and participates in the import of mitochondrial preproteins into the mitochondria (10). The highest degree of identity occurs between the N-terminal regions of the proteins, from amino acids 35 to 165 of metaxin and amino acids 43 and 185 of Tom37; no significant sequence identity occurs within the C-terminal halves of the proteins (data not shown). Another apparent difference exists in the mitochondrial outer membrane targeting domains of the two proteins, because Tom37 has an N-terminal targeting sequence, and metaxin has a C-terminal targeting sequence.

Given the similarity in the subcellular locations and sequence of metaxin and Tom37, we tested the hypothesis that metaxin functions in mitochondrial import in a manner similar to that of Tom37. Preadrenodoxin, labeled with 125I, was incubated with purified mitochondria that had been preincubated in the absence of antibodies or in the presence of either anti-metaxin antibodies or antibodies against porin, a mitochondrial outer membrane protein that is not involved in mitochondrial protein import. The anti-metaxin antibodies inhibited uptake of the preadrenodoxin in a dose-dependent fashion (Fig. 6). Mitochondria treated with the highest concentrations of anti-metaxin imported 10% of the preadrenodoxin relative to untreated mitochondria. Preincubation in the presence of anti-porin antibodies had no effect on preadrenodoxin import. Thus, metaxin acts in the mitochondrial outer membrane to promote import of mitochondrial preproteins.


Fig. 6. Antibodies against metaxin inhibit import of preadrenodoxin. Mouse liver mitochondria (100 µg) were incubated with the indicated amounts of the antibodies in 50 µl of the import buffer at 0 °C for 60 min, washed once with the import buffer, and then subjected to import at 30 °C for 50 min. pAd, preadrenodoxin; mAd, mature form of adrenodoxin.
[View Larger Version of this Image (33K GIF file)]


We have attempted to answer the question of whether metaxin is a functional mammalian homologue of Tom37 by assessment of the ability of metaxin cDNA to restore a wild type phenotype to YSG1@, a tom37 strain of Saccharomyces cerevisiae (kindly provided by Sabine Rospert and Gottfried Schatz, Biozentrum, Basel). The plasmid pRS316OXmet, which contains the metaxin cDNA, did not restore the ability of the mutant strain to grow at 37 °C on dextrose-containing medium, whereas pEL204, which contains the Tom37 gene, did complement the mutation. Although metaxin mRNA was present, the protein was not detectable in yeast transfected with metaxin cDNA; this failure to complement the tom37 mutation may be due to instability of metaxin in yeast, which may in turn be a consequence of an inability of the protein to bind productively to yeast mitochondria.

Data Base Searches Reveal Several Additional Homologous Proteins

Metaxin shares sequence identity with a Caenorhabditis elegans hypothetical protein (GenBankTM accession number P34599[GenBank]); a 29% identity over 222 amino acids was determined by the FASTA algorithm. The function of the protein encoded by this gene is unknown, and it lacks any sequences resembling the C-terminal transmembrane domain of metaxin. Metaxin also has 29% identity over 206 amino acids with failed axon connections protein (FAX), the product of a Drosophila gene that in its heterozygous state exacerbates the phenotype of abl tyrosine kinase null mutants (25). FAX is thought to function as a participant in the abl kinase pathway, but its precise biochemical function is unknown. Metaxin resembles the central 300 amino acids of FAX, but FAX contains N- and C-terminal domains that are unlike metaxin and are rich in charged residues, alanine and proline. FAX also does not contain any detectable transmembrane sequences reminiscent of a mitochondrial outer membrane targeting domain, and its subcellular location has yet to be determined.

BLAST searches of the protein data base (26) with metaxin, FAX, and the C. elegans hypothetical proteins revealed that each has weak sequence similarity to numerous glutathione S-transferases. The GST superfamily is large and highly variable in sequence, but a consensus sequence for GSTs has been determined (27). Metaxin and its relatives partially conform to this consensus and contain the most sequence identity to one another in the regions that match the GST consensus. In particular, those residues determined by x-ray crystallography to be involved in conferring structural stability to GSTs (28) are almost completely conserved among GSTs and between metaxin and its relatives, whereas residues involved in binding to glutathione are not (data not shown). These findings suggest that metaxin and its relatives probably do not function as GSTs.


DISCUSSION

The metaxin gene was discovered during investigations of its two flanking genes, which encode glucocerebrosidase and thrombospondin 3. We describe here the characterization of metaxin and conclude that it is a mitochondrial outer membrane protein that functions as an import receptor for mitochondrial preproteins. Metaxin resembles the yeast mitochondrial preprotein import subunit, Tom37, in sequence, in outer membrane location, and in participation in mitochondrial import. Although many components of the fungal mitochondrial protein import apparatus have been characterized, only two mammalian import proteins, human Tom20 and human Tim17, have heretofore been described at the molecular level (29-32). Mammalian Tom 20 and Tim 17 are similar to the yeast proteins at the amino acid sequence level, and the finding of a third mammalian protein that resembles a yeast mitochondrial protein import component suggests a general conservation between fungi and mammals in their mechanisms of uptake of proteins into mitochondria.

Is metaxin a functional mammalian homologue of S. cerevisiae Tom37? Our results indicate that, although metaxin and Tom37 both participate in preprotein import, they differ in some important aspects. First, the amino acid sequence identity between metaxin and Tom37 is significant only within the N-terminal regions of the proteins. The presence of divergent C termini within metaxin and Tom37 suggests that some functional characteristics of the two proteins differ. Second, the mechanisms by which metaxin and Tom37 associate with the outer membrane are apparently different. Tom37 contains at its N terminus an amphiphilic, positively charged sequence followed by a predicted transmembrane sequence; these sequences are thought to function like the N-terminal signal anchor domain of Tom70 (10). Metaxin contains neither of these sequences at its N terminus. These differences in targeting domains may indicate differences in the mechanism of insertion into the outer membrane and/or in the arrangement of the proteins in the outer membrane. Third, metaxin cannot carry out the biochemical functions of Tom37, because metaxin cDNA fails to complement the tom37 mutation of S. cerevisiae. The inability of the yeast import apparatus to recognize the C-terminal targeting sequence of metaxin or the failure of metaxin to oligomerize with the partners of Tom37 in yeast may preclude metaxin from reaching the yeast mitochondrial outer membrane and may result in the rapid degradation of metaxin. Metaxin therefore appears to bear a general structural and functional resemblance to Tom37 but has diverged evolutionarily from Tom37 in several key details.

With the characterization of metaxin as a mitochondrial import protein, the metaxin-null mutation (6) represents the first reported mammalian inherited deficiency in a mitochondrial import protein. Mutations in fungal mitochondrial import proteins, in contrast, have been well studied, and phenotypes of such mutants range from temperature-sensitive deficiency in respiration to lethality. Yeast lacking Tom37 are unable to grow on any carbon source at 37 °C but grow on both fermentable and nonfermentable carbon sources at 23 °C (10). Mouse metaxin-null cells appear to have limited replicative potential in vivo, because metaxin-null mutant embryos survive to the blastocyst stage and implant, but by day 6.5 the embryos die and become resorbed.2 Precise evaluation of the consequences of a deficiency of metaxin is complicated by the possibility that metaxin and/or metaxin mRNA contributed by the fertilized egg persists long enough to enable the blastocyst to develop and implant. The capacity of a zygote entirely lacking metaxin to divide and differentiate may therefore be even more limited than that observed in metaxin-null mutant mice.

Several possibilites exist for the disparity between the severe phenotype of metaxin-null mutant mice and the conditional phenotype of Tom37 mutant yeast. Tom37 facilitates import of selected mitochondrial proteins (10); presumably yeast lacking Tom37 import proteins into mitochondria by means of other outer membrane receptors, such as Tom 22/20. Metaxin may import a broader subset of mitochondrial proteins than does Tom37, and other receptors may be less able to compensate for the lack of metaxin than for Tom37. In this case, all embryonic cell types would be compromised by a lack of metaxin. Alternatively, embryos lacking metaxin may be defective in the function of a certain cell type, which may result from the action of metaxin in stimulating import of a subset of proteins that are strictly required for survival of that cell type in the early mouse embryo. Examination of metaxin-null blastocysts during outgrowth in vitro might permit identification and phenotypic characterization of cell types affected by metaxin deficiency.

In yeast, Tom37 forms a heterodimer with Tom70, and they act together as a receptor for a subset of mitochondrial preproteins (10). A chaperone, MSF, purified from rat liver cytosol, complexes specifically with mitochondrial precursor proteins and mediates their association with Tom37-Tom70 (33). Although a yeast counterpart of MSF has not yet been described, the productive interaction between MSF and yeast Tom37-Tom70 suggests that such a homologue exists. After the MSF-preprotein complex docks at the Tom37-Tom70 site on the outer membrane, ATP stimulates the dissociation of MSF from the preprotein and the Tom37-Tom70 complex, and the preprotein is then transferred to another outer membrane receptor complex, Tom20-Tom22, to begin traversal of the outer membrane pore (33). Thus far, no other protein besides metaxin has been found to have significant sequence identity to Tom37, but Tom70 belongs to the tetratricopeptide family of proteins. Tom37 also contains a tetratricopeptide motif that is partially conserved in metaxin. Tetratricopeptide sequences are involved in the association of Tom20 and Tom70 with one another (34), and these motifs may also mediate associations between Tom37, and perhaps metaxin, and other subunits of the import machinery.

In mammalian mitochondria, docking of the preprotein at the outer membrane and subsequent passage of the preprotein to the outer membrane pore appear to occur in stages similar to those observed in yeast (35), but the components of the outer membrane that facilitate this passage are only beginning to be characterized. A component of the outer membrane receptor for the MSF-preprotein complex, OM37, has been characterized with a specific antiserum but has not yet been characterized at the molecular level (35). OM37 and metaxin appear to be distinct entities, because antibodies against each protein fail to recognize the other.3 An important next step in the characterization of the function of metaxin and its relation to that of Tom37 is the evaluation of its participation in the recruitment of MSF-preprotein complexes to the mitochondrial outer membrane.

The sequence directing metaxin to the mitochondrial outer membrane resembles the C-terminal signal anchor sequences of monoamine oxidase and Bcl-2, although metaxin contains 15 amino acids C-terminal to the signal anchor that are not present in the other two proteins. The positively charged character of these outer membrane targeting sequences probably allows them to utilize the same chaperones and receptors that classical mitochondrial matrix signals do, whereas the hydrophobic stretch serves as a transmembrane domain. Interestingly, the C terminus of metaxin contains six consecutive acidic residues; clusters of acidic residues in Tom22 are thought to be important in the binding of mitochondrial presequences to the trans side of the mitochondrial outer membrane during import (36), although this finding is controversial (37, 38).

We observed that exogenous metaxin was not associated completely with mitochondria, whereas endogenous metaxin was found exclusively in mitochondria. Incomplete targeting is presumed to occur as a result of saturation of specific chaperones and receptors involved in correctly targeting the protein. We also observed that metaxin lacking its 15 C-terminal amino acids was more efficiently targeted to mitochondria than was the intact protein. The six consecutive acidic residues mentioned above may inhibit integration of overexpressed metaxin into the mitochondrial outer membrane, because an overall positive charge is generally a requirement for import. However, we cannot rule out the possibility that a concentration threshold exists for efficient targeting of metaxin to mitochondria and that full-length metaxin has exceeded that threshold as a result of its relatively high expression level. On the other hand, metaxin missing these C-terminal amino acids and the putative transmembrane region was severely compromised in its association with mitochondria, thereby demonstrating that metaxin associates with mitochondria largely by means of a C-terminal signal anchor. A residual amount of metaxin lacking its signal anchor does continue to associate with mitochondria, perhaps by specifically dimerizing with another protein of the mitochondrial outer membrane. Such putative interactions could also explain why the C-terminal signal anchor domain alone acts rather weakly in directing EGFP to mitochondria.

The relationships among metaxin, FAX, and the C. elegans hypothetical proteins are unclear. None of these relatives of metaxin contains identifiable N- or C-terminal mitochondrial targeting signals, and they are therefore likely to reside in other compartments of the cell. Perhaps these metaxin-like sequences have a common molecular function that can be employed in various cellular locations. The distant similarity of metaxin and its relatives to the GSTs indicates that the former class of proteins may be members of the ancient GST superfamily, although further information about the tertiary structure of metaxin will be needed to properly address this question. The conservation in metaxin of residues that in GSTs are involved in maintaining proper tertiary structure and the lack of conservation of residues that in GSTs are responsible for binding glutathione suggest that metaxin adopts a GST-like conformation but is not an enzymatically active GST.


FOOTNOTES

*   This work was supported in part by National Institutes of Health Grant AG051361 (to P. B.). A preliminary report of this work has been published in abstract form (Ref. 1).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   Recipient of National Institute of Health National Research Service Award 5F32GM17395-02.
par    To whom correspondence should be addressed: Dept. of Biochemistry, Box 357350, University of Washington, Seattle, WA 98195. Tel.: 206-543-1789; Fax: 206-685-4426; E-mail: bornsten{at}u.washington.edu.
1   The abbreviations used are: GST, glutathione S-transferase; EGFP, enhanced green fluorescent protein; FAX, failed axon connections protein; MSF, mitochondrial import stimulatory factor.
2   E. I. Ginns, unpublished data.
3   L. C. Armstrong, T. Komiya, B. E. Bergman, K. Mihara, and P. Bornstein, unpublished observations.

Acknowledgments

We thank Hans Vos for assistance with computer analysis of metaxin homologies, Paulette Brunner and Susan Anderson for assistance with confocal microscopy, and Gottfried Schatz for helpful comments on the manuscript.


REFERENCES

  1. Armstrong, L. C., Vos, H., Bergman, B., and Bornstein, P. (1995) Mol. Biol. Cell 6, 434 (abstr.)
  2. Vos, H. L., Devarayalu, S., De Vries, Y., and Bornstein, P. (1992) J. Biol. Chem. 267, 12192-12196 [Abstract/Free Full Text]
  3. Bornstein, P., and Sage, E. H. (1994) Methods Enzymol. 245, 62-85 [Medline] [Order article via Infotrieve]
  4. Bornstein, P., Devarayalu, S., Edelhoff, S., and Disteche, C. M. (1993) Genomics 15, 607-613 [CrossRef][Medline] [Order article via Infotrieve]
  5. Beutler, E. (1995) Adv. Genet. 32, 17-49 [Medline] [Order article via Infotrieve]
  6. Bornstein, P., McKinney, C. E., LaMarca, M. E., Winfield, S., Shingu, T., Devarayalu, S., Vos, H. L., and Ginns, E. I. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 4547-4551 [Abstract]
  7. Collins, M., and Bornstein, P. (1996) Nucleic Acids Res. 24, 3661-3669 [Abstract/Free Full Text]
  8. Iruela-Arispe, M. L., Liska, D. J., Sage, E. H., and Bornstein, P. (1993) Dev. Dyn. 197, 40-56 [Medline] [Order article via Infotrieve]
  9. Qabar, A. N., Lin, Z., Wolf, F. W., O'Shea, K. S., Lawler, J., and Dixit, V. (1994) J. Biol. Chem. 269, 1262-1269 [Abstract/Free Full Text]
  10. Gratzer, S., Lithgow, T., Bauer, R. E., Lamping, E., Paltauf, F., Kohlwein, S. D., Haucke, V., Junne, T., Schatz, G., and Horst, M. (1995) J. Cell Biol. 129, 25-34 [Abstract]
  11. Fleischer, S., and Kervina, M. (1974) Methods Enzymol. 31, 6-40 [Medline] [Order article via Infotrieve]
  12. Srere, P. A. (1969) Methods Enzymol. 13, 3-5
  13. Trouet, A. (1974) Methods Enzymol. 31, 323-329 [Medline] [Order article via Infotrieve]
  14. Stolzenbach, F. (1966) Methods Enzymol. 9, 278-288
  15. Schimmel, S. D., Kent, C., Bischoff, R., and Vagelos, P. R. (1973) Proc. Natl. Acad. Sci. U. S. A. 70, 3195-3199 [Abstract]
  16. Swanson, M. A. (1955) Methods Enzymol. 2, 541-543
  17. Schnaitmann, C., and Greenawalt, J. W. (1968) J. Cell Biol. 38, 158-175 [Abstract/Free Full Text]
  18. Komiya, T., Sakaguchi, M., and Mihara, K. (1996) EMBO J. 15, 399-407 [Abstract]
  19. Roise, D., and Schatz, G. (1988) J. Biol. Chem. 263, 4509-4511 [Free Full Text]
  20. Rost, B., Casadio, R., Fariselli, P., and Sander, C. (1995) Protein Sci. 4, 521-533 [Abstract/Free Full Text]
  21. Nguyen, M., Millar, D. G., Yong, V. W., Korsmeyer, S. J., and Shore, G. C. (1993) J. Biol. Chem. 268, 25265-25268 [Abstract/Free Full Text]
  22. Mitoma, J., and Ito, A. (1992) J. Biochem. 111, 20-24 [Abstract]
  23. Hase, T., Müller, U., Riezman, H., and Schatz, G. (1984) EMBO J. 3, 3157-3164 [Abstract]
  24. Jarausch, J., and Kadenbach, B. (1985) Eur. J. Biochem. 146, 219-225 [Abstract]
  25. Hill, K. K., Bedian, V., Juang, J.-L., and Hoffmann, F. M. (1995) Genetics 141, 595-606 [Abstract/Free Full Text]
  26. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) J. Mol. Biol. 215, 403-410 [CrossRef][Medline] [Order article via Infotrieve]
  27. Koonin, E. V., Mushegian, A. R., Tatusov, R. L., Altschul, S. F., Bryant, S. H., Bork, P., and Valencia, A. (1994) Protein Sci. 3, 2045-2054 [Abstract/Free Full Text]
  28. Dirr, H., Reinemer, P., and Huber, R. (1994) Eur. J. Biochem. 220, 645-661 [Abstract]
  29. Hanson, B., Nuttall, S., and Hoogenraad, N. (1996) Eur. J. Biochem. 235, 750-753 [Abstract]
  30. Goping, I. S., Millar, D. G., and Shore, G. C. (1995) FEBS Lett. 373, 45-50 [CrossRef][Medline] [Order article via Infotrieve]
  31. Seki, N., Moczko, M., Nagase, T., Zufall, N., Ehmann, B., Dietmeier, K., Schäfer, E., Nomura, N., and Pfanner, N. (1995) FEBS Lett. 375, 307-310 [CrossRef][Medline] [Order article via Infotrieve]
  32. Bömer, U., Rassow, J., Zufall, N., Pfanner, N., Meijer, M., and Maarse, A. C. (1996) J. Mol. Biol. 262, 389-395 [CrossRef][Medline] [Order article via Infotrieve]
  33. Hachiya, N., Mihara, K., Suda, K., Horst, M., Schatz, G., and Lithgow, T. (1995) Nature 376, 705-708 [CrossRef][Medline] [Order article via Infotrieve]
  34. Haucke, V., Horst, M., Schatz, G., and Lithgow, T. (1996) EMBO J. 15, 1231-1237 [Abstract]
  35. Komiya, T., and Mihara, K. (1996) J. Biol. Chem. 271, 22105-22110 [Abstract/Free Full Text]
  36. Bollinger, L., Junne, T., Schatz, G., and Lithgow, T. (1995) EMBO J. 14, 6318-6326 [Abstract]
  37. Court, D. A., Kleene, R., Neupert, W., and Lill, R. (1996) FEBS Lett. 390, 73-77 [CrossRef][Medline] [Order article via Infotrieve]
  38. Nakai, M., Kinoshita, K., and Endo, T. (1995) J. Biol. Chem. 270, 30571-30575 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.